Study to Investigate the Clinical Benefits of Dietary Supplement Quercetin for Managing Early Mild Symptoms of COVID-19

NCT04861298 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

100

Enrollment

OTHER

Sponsor class

Conditions

COVID-19

Interventions

DRUG: standard of care for COVID-19 as per the hospital guidelines
DIETARY_SUPPLEMENT: Quercetin Phytosome (QP)

Sponsor

King Edward Medical University